A comparison of dynamic contrast-enhanced CT and MR imaging-derived measurements in patients with cervical cancer

Clinical Physiology and Functional Imaging

Volumn 33, Issue 2, 2013, Pages 150-161

  Kim, Sun Mo ^a   Haider, Masoom A ^a,b   Milosevic, Michael ^a,b   Yeung, Ivan W T ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Comparison study; Modified Tofts model; Pharmacokinetic analysis; Population averaged AIF; Reference tissue method

Indexed keywords

GADODIAMIDE;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; DYNAMIC CONTRAST ENHANCED COMPUTER ASSISTED TOMOGRAPHY; DYNAMIC CONTRAST ENHANCED NUCLEAR MAGNETIC RESONANCE IMAGING; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMAGING AND DISPLAY; KINETICS; MEASUREMENT; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADULT; AGED; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IOHEXOL; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; UTERINE CERVICAL NEOPLASMS;

EID: 84873450663     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/cpf.12010     Document Type: Article

References (29)

1. Ay MR, Zaidi H. Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET. Eur J Nucl Med Mol Imaging (2006); 33: 1301-1313.
2. Bae KT, Shah AJ, Shang SS, Wang JH, Chang S, Kanematsu M, Hildebolt CF. Aortic and Hepatic Contrast Enhancement with Abdominal 64-MDCT in Pediatric Patients: Effect of Body Weight and Iodine Dose. AJR (2008); 191: 1589-1594.
3. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0T: preliminary results. Radiology (2004); 230: 652-665.
4. Bellomi M, Petralia G, Sonzogni A, Zampino MG, Rocca A. CT Perfusion for the Monitoring of Neoadjuvant Chemotherapy and Radiation Therapy in Rectal Carcinoma: Initial Experience. Radiology (2007); 244: 486-493.
5. Bisdas S, Medov L, Baghi M, Konstantinou GN, Wagenblast J, Thng CH, Vogl TJ, Koh TS. A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract. Eur Radiol (2008); 18: 843-850.
6. Bisdas S, Baghi M, Wagenblast J, Bisdas T, Thng CH, Mack MG, Koh TS, Ernemann U. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results. Clin Physiol Funct Imaging (2009); 29: 339-346.
7. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986); 1: 307-310.
8. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet (1995); 346: 1085-1087.
9. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res (1999); 8: 135-160.
10. Brink JA. Contrast optimization and scan timing for single and multidector-row computed tomography. J Comput Assist Tomogr (2003); 27: S3-S8.
11. Dawson P. Functional imaging in CT. Eur J Radiol (2006); 60: 331-340.
12. 1) at high magnetic field strengths. Magn Reson Imaging (2007); 25: 733-735.
13. Galbraith SM, Maxwell RJ, Lodge MA, Tozer GM, Wilson J, Taylor NJ, Stirling JJ, Sena L, Padhani AR, Rustin GJ. Combretastatin A4 Phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. J Clin Oncol (2003); 21: 2831-2842.
14. Gong QY, Brunt JN, Romaniuk CS, Oakley JP, Tan LT, Roberts N, Whitehouse GH, Jones B. Contrast enhanced dynamic MRI of cervical carcinoma during radiotherapy: early prediction of tumour regression rate. Br J Radiol (1999); 72: 1177-1184.
15. Gutierreza DR, Wells K, Diaz Montesdeocab O, Moran Santana A, Mendichovszky IA, Gordon I. Partial volume effects in dynamic contrast magnetic resonance renal studies. Eur J Radiol (2010); 75: 221-229.
16. Haider MA, Milosevic M, Fyles A, Sitartchouk I, Yeung I, Henderson E, Lockwood G, Lee TY, Roberts TP. Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. Int J Radiat Oncol Biol Phys (2005); 62: 1100-1107.
17. Haider MA, Sitartchouk I, Roberts TP, Fyles A, Hashmi AT, Milosevic M. Correlations between dynamic contrast-enhanced magnetic resonance imaging-derived measures of tumor microvasculature and interstitial fluid pressure in patients with cervical cancer. J Magn Reson Imaging (2007); 25: 153-159.
18. Hawighorst H, Weikel W, Knapstein PG, Knopp MV, Zuna I, Schönberg SO, Vaupel P, van Kaick G. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res (1998); 4: 2305-2312.
19. Henderson E, Milosevic MF, Haider MA, Yeung IW. Functional CT imaging of prostate cancer. Phys Med Biol (2003); 48: 3085-3100.
20. Hsiao IT, Liao YP, Liu HL. Study of onset time-shift and injection duration in DCE-MRI: a comparison of a reference region model with the general kinetic model. NMR Biomed (2010); 23: 375-381.
21. Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, Jackson A, Watson Y, Davies K, Jayson GC. Experimentally-Derived Functional Form for a Population-Averaged High-Temporal-Resolution Arterial Input Function for Dynamic Contrast-Enhanced MRI. Magn Reson Med (2006); 56: 993-1000.
22. Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, Henkelman RM. T1, T2 Relaxation and Magnetization Transfer in Tissue. Magn Reson Med (2005); 54: 507-512.
23. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging (1999); 10: 223-232.
24. Waaijer A, Prokop M, Velthuis BK, Bakker CJ, de Kort GA, van Leeuwen MS. Circle of Willis at CT angiography: dose reduction and image quality-reducing tube voltage and increasing tube current settings. Radiology (2007); 242: 832-839.
25. Ward J, Chalmers AG, Guthrie AJ, Larvin M, Robinson PJ. T2-weighted and dynamic enhanced MRI in acute pancreatitis: comparison with contrast enhanced CT. Clin Radiol (1997); 52: 109-114.
26. Yang X, Knopp MV. Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review. J Biomed Biotechnol (2011); 2011: 732848.
27. Yang C, Karczmar GS, Medved M, Stadler WM. Estimating the arterial input function using two reference tissues in dynamic contrast-enhanced MRI studies: fundamental concepts and simulations. Magn Reson Med (2004); 52: 1110-1117.
28. Yang C, Stadler WM, Karczmar GS, Milosevic M, Yeung I, Haider MA. Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT. Magn Reson Med (2010); 63: 1601-1609.
29. Yankeelov TE, Luci JJ, Lepage M, Li R, Debusk L, Lin PC, Price RR, Gore JC. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging (2005); 23: 519-529.